11.18.09 Cardioxyl Pharmaceuticals announces pre-clinical results on lead clinical candidate, CXL-1020 at American Heart Association Scientific Sessions 2009
10.29.09 Cardioxyl Pharmaceuticals announces late-breaker at American Heart Association Conference
09.15.09 Cardioxyl Pharmaceuticals presents new data at the 13th annual Scientific Meeting of the Heart Failure Society of America
09.10.09 Cardioxyl Pharmaceuticals to present data at two cardiology conferences
07.01.09 Cardioxyl Pharmaceuticals initiates phase I/IIa study in heart failure
Cardioxyl has developed proprietary expertise in the biology, physiology and chemistry of nitroxyl donors
View More
Cardioxyl's lead compound enters clinical development for Acute Decompensated Heart Failure
